Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Inventory (2023 - 2025)

Historic Inventory for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to $18.0 million.

  • Genmab A's Inventory rose 10000.0% to $18.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.0 million, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $18.0 million for FY2025, which is 10000.0% up from last year.
  • According to the latest figures from Q4 2025, Genmab A's Inventory is $18.0 million, which was up 10000.0% from $14.0 million recorded in Q3 2025.
  • Genmab A's Inventory's 5-year high stood at $18.0 million during Q4 2025, with a 5-year trough of -$8.0 million in Q4 2023.
  • Moreover, its 3-year median value for Inventory was $9.0 million (2024), whereas its average is $5.8 million.
  • Data for Genmab A's Inventory shows a peak YoY increase of 80000.0% (in 2025) and a maximum YoY decrease of 10000.0% (in 2025) over the last 5 years.
  • Over the past 3 years, Genmab A's Inventory (Quarter) stood at -$8.0 million in 2023, then surged by 212.5% to $9.0 million in 2024, then surged by 100.0% to $18.0 million in 2025.
  • Its Inventory stands at $18.0 million for Q4 2025, versus $14.0 million for Q3 2025 and $13.0 million for Q2 2025.